Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
NCT01131689
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
sorafenib, TS-1
Sponsor
Samsung Medical Center